Peptide Routes of Administration

How peptides reach the body — subcutaneous, intramuscular, oral, nasal, sublingual, and topical delivery methods compared.

The route of administration (ROA) significantly affects a peptide's bioavailability, onset time, and therapeutic reach. Choosing the right delivery method is as important as choosing the right dose. This guide covers the six primary routes used in peptide research and clinical practice.

Route Comparison Table

Route Bioavailability Onset Best For Typical Peptides
Subcutaneous (SubQ) ~90–100% 15–30 min Most peptides, systemic delivery BPC-157, CJC-1295, Semaglutide
Intramuscular (IM) ~90–100% 10–20 min Localized injury, deep tissue repair BPC-157, TB-500, IGF-1 LR3
Oral ~1–10% 30–60 min GI-targeted peptides, some GLP-1s BPC-157 (oral), KPV, Semaglutide (Rybelsus)
Sublingual ~10–30% 15–30 min Avoiding GI degradation, convenience BPC-157, Selank
Intranasal ~10–50% 5–15 min CNS-targeting nootropic peptides Semax, Selank, Oxytocin
Topical Variable (local) 30–60 min Skin, localized tissue, cosmetic GHK-Cu, BPC-157 cream

Subcutaneous Injection (SubQ)

The most common route for peptide administration. A short, fine needle (insulin syringe, 29–31 gauge) delivers the peptide into the fat layer just beneath the skin.

Advantages

  • Highest bioavailability (~90–100%)
  • Consistent, predictable absorption
  • Easy to self-administer at home
  • Minimal pain with insulin-gauge needles
  • Flexible injection sites (abdomen, thigh, upper arm)

Common Injection Sites

  • Abdomen — 2 inches from navel (most common)
  • Thigh — Outer middle third
  • Upper arm — Outer/back area
  • Rotate sites to prevent lipodystrophy

Best Practices

  • Pinch skin at 45° angle, insert needle
  • Inject slowly and steadily
  • Use a new syringe for each injection
  • Alcohol-swab the injection site first
  • Wait 10 seconds before withdrawing needle

Used by: BPC-157, TB-500, CJC-1295, Ipamorelin, Semaglutide, Tirzepatide, Epithalon, Thymosin Alpha-1, and most other injectable peptides.

Intramuscular Injection (IM)

Delivers the peptide directly into muscle tissue for faster absorption and localized effects.

Advantages

  • Faster absorption than SubQ
  • Targeted delivery near injury site
  • Larger volume capacity per injection

Considerations

  • Slightly more painful than SubQ
  • Requires longer needle (25–27 gauge)
  • Risk of hitting nerves or blood vessels
  • Best for localized muscle/tendon injuries

Used by: BPC-157 (near injury), TB-500, IGF-1 LR3 (targeted muscle groups).

Oral Administration

Most peptides are degraded by stomach acid and enzymes, making oral delivery challenging. However, certain peptides are specifically designed for or resistant to GI breakdown.

Advantages

  • Non-invasive, no needles
  • Direct GI tract contact for gut-targeting peptides
  • Convenient and easy to administer

Limitations

  • Very low systemic bioavailability (1–10%)
  • Most peptides destroyed by digestive enzymes
  • Higher doses needed to compensate for degradation
  • Absorption affected by food, pH, transit time

Notable oral peptides: BPC-157 (uniquely stable in gastric acid), KPV (oral capsules), Semaglutide (Rybelsus — formulated with absorption enhancer SNAC). BPC-157 is one of the few peptides that maintains significant activity when taken orally, making it particularly valuable for gut-related conditions.

Intranasal Delivery

Sprayed into the nasal cavity for rapid absorption through the nasal mucosa. Particularly effective for peptides targeting the central nervous system, as the nose-to-brain pathway bypasses the blood-brain barrier.

Advantages

  • Rapid onset (5–15 minutes)
  • Direct nose-to-brain pathway for CNS peptides
  • Non-invasive and easy to use
  • Bypasses GI degradation

Considerations

  • Variable absorption depending on nasal congestion
  • Limited volume per spray (~0.1 mL)
  • May cause nasal irritation with prolonged use
  • Requires specific nasal spray bottles

Used by: Semax, Selank, Oxytocin, DSIP. These nootropic and neuroprotective peptides benefit from the direct CNS access that nasal delivery provides.

Topical Application

Applied directly to the skin in cream, gel, or serum form. Primarily used for localized skin effects and cosmetic applications.

Advantages

  • Targeted skin/tissue delivery
  • Non-invasive
  • Easy self-application

Limitations

  • Very limited systemic absorption
  • Effectiveness depends on peptide size and formulation
  • Best suited for small peptides (<500 Da)

Used by: GHK-Cu (skin rejuvenation, wound healing, hair growth), copper peptide serums, and some BPC-157 cream formulations for localized tissue repair.

How to Choose Your Route

For systemic whole-body effects

Subcutaneous injection — highest bioavailability, consistent absorption, works for most peptides. Use our calculator to determine exact dosing.

For localized injury repair

Intramuscular or SubQ near the injury site. Compounds like BPC-157 and TB-500 are most effective when injected close to the damaged tissue.

For gut health & GI conditions

Oral delivery makes the most sense for BPC-157 and KPV when targeting the digestive tract directly.

For cognitive enhancement

Intranasal delivery for Semax and Selank — the nose-to-brain pathway provides direct CNS access.

For skin rejuvenation

Topical GHK-Cu serums deliver copper peptides directly to the skin for collagen synthesis and wound healing.